The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.
Clin J Oncol Nurs
; 28(4): 397-405, 2024 Jul 19.
Article
em En
| MEDLINE
| ID: mdl-39041688
ABSTRACT
BACKGROUND:
Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited.OBJECTIVES:
This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center.METHODS:
Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a three-year period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated.FINDINGS:
The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Segurança do Paciente
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article